跳至主要内容
临床试验/TCTR20200314001
TCTR20200314001已完成未知

Circulating biomarkers and disease activity in systemic sclerosis-associated interstitial lung disease

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 17 人开始时间: 2020年3月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 N/A (No limit) 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Confirmed diagnosis of systemic sclerosis-associated with interstitial pneumonia in SSc-ILD group
  • 2. Healthy subject with no interstitial lung disease in control group

排除标准

  • 1. Younger than 18 years old
  • 2. Pregnancy
  • 3. Patients who had the following conditions: adenocarcinoma of any organs, bacterial or viral pneumonia, and patients who cannot perform pulmonary function tests

研究者

相似试验

已完成
不适用
Characterization of circulating biomarkers for monitoring abdominal aortic aneurysmsI71.4Abdominal aortic aneurysm, without mention of rupture
DRKS00031892Klinik für Gefäßchirurgie und Endovaskuläre Chirurgie, Universitätsklinikum Heidelberg300
已完成
不适用
Biomarkers for Prognosis of Ambulatory Chronic Heart Failure PatientsHeart Failure
NCT01113866University of Parma124
招募中
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-Part Research: Part BF00.2Alzheimer's diseaseMild Cognitive ImpairmentF00.0F00.1F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorder
DRKS00003705QUALISSIMA150
已完成
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical study
NL-OMON38870Vrije Universiteit Medisch Centrum15
已完成
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-part Research: Part AHealthy SubjectsMild Cognitive ImpairmentAlzheimer's disease / Alzheimer dementiaF00.0F00.1F00.2F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorder
DRKS00003721QUALISSIMA40